Equine herpesvirus vaccine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S204100, C435S007100

Reexamination Certificate

active

10897984

ABSTRACT:
A vaccine for protecting a horse against diseases associated with EHV-1 and/or EHV-4 is provided. The vaccine commonly includes inactivated EHV-1 (e.g., chemically inactivated EHV-1 KyA virus) and an adjuvant. The adjuvant can include a cross-linked olefinically unsaturated carboxylic acid polymer which may have bioadhesive properties. The vaccine may also include antigens against other equine pathogens such as inactivated EHV-4 and inactivated A1 and/or A2 strains of equine influenza virus. Methods for protecting horses against diseases associated with EHV-1 and/or EHV-4 and methods of producing the equine herpesvirus vaccine are also provided.

REFERENCES:
patent: 3920811 (1975-11-01), Lund
patent: 4083958 (1978-04-01), Bryans
patent: 4110433 (1978-08-01), Purdy, III
patent: 4225582 (1980-09-01), Crandell
patent: 4500513 (1985-02-01), Brown et al.
patent: 4509949 (1985-04-01), Huang et al.
patent: 4615697 (1986-10-01), Robinson
patent: 4758641 (1988-07-01), Hsu
patent: 5084271 (1992-01-01), Studdert
patent: 5221722 (1993-06-01), Sehm
patent: 5292653 (1994-03-01), Kit et al.
patent: 5462734 (1995-10-01), Letchworthill et al.
patent: 5470718 (1995-11-01), O' Callaghan
patent: 5707629 (1998-01-01), O'Callaghan
patent: 5795578 (1998-08-01), O'Callaghan
patent: 5843451 (1998-12-01), Compans et al.
patent: 5853715 (1998-12-01), Macek et al.
patent: 5922327 (1999-07-01), Crabb et al.
patent: 6025181 (2000-02-01), Onions et al.
patent: 6083511 (2000-07-01), Onions et al.
patent: 6171502 (2001-01-01), Studdert et al.
patent: 6193983 (2001-02-01), Crabb et al.
patent: 6207166 (2001-03-01), Audonnet et al.
patent: 6225111 (2001-05-01), Cochran et al.
patent: 6531136 (2003-03-01), Studdert et al.
patent: 6544526 (2003-04-01), Crabb et al.
patent: 6803041 (2004-10-01), Mellencamp
patent: 0 532 833 (1993-03-01), None
patent: 0 978 286 (2000-02-01), None
patent: WO 97/22701 (1997-06-01), None
Yasunaga et al (Journal of Veterinary Medical Science. Jul. 2000; 62(7), pp. 687-691).
Allen, G.P.; “Respiratory Infections by Equine Herpesvirus Types 1 and 4”;Equine Respiratory Diseases; P. Lekeux (Ed.), Feb. 28, 2002; pp. 1-14; International Veterinary Information Service, Ithaca, New York, USA.
Bagust et al., “Studies on Equine Herpesviruses”,Australian Veterinary Journal, 46, Sep. 1970 (pp. 421-427).
Baker, “Vaccines for EHV1”,The Veterinary Record, Jan. 1983 (pp. 110-111).
Becker, “Prophylakitsche Impfung gegen den EHV (Equine Herpesvirus)-Abort”,Tierärztl. Prax., 16, 1988, (pp. 61-63).
Belák et al., “Passive Immunization of Foals to Prevent Respiratory Disease Caused by Equine Herpesvirus Type 2”,Zbl. Vet. Med. B, 27, 1980, (pp. 826-830).
Borgen et al., “Equine Herpesvirus 1: Biological and Biophysical Comparison of Two Viruses from Different Clinical Entities”,Intervirology, 4, 1974 (pp. 189-198).
Bumgardner, “Lymphocytes from ponies experimentally infected with equine herpesvirus 1: Subpopulation dynamics and their response to mitogens”,Am. J. Vet. Res., 43, Jul. 1982 (pp. 1308-1310).
Burrows et al., “Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype 1 virus”,The Veterinary Record, Apr. 1984 (pp. 369-374).
Campbell et al., “Equine herpesvirus type 1 (EHV1)”,Veterinary bulletin,Commonwealth Agricultural Bureaux, 53, Feb. 1983 (pp. 135-146).
Carbopol®, “The Proven Polymers in Pharmaceuticals”,Pharmaceutical Bulletin 2, Apr. 1995 (8 pgs).
Coggins, “Viral Respiratory Disease”,Veterinary Clinics of North America: Large Animal Practice, 1, May 1979 (pp. 59-72).
Coignoul et al., “Pathogenicity of Equine Herpesvirus 1 Subtype 2 for Foals and Adult Pony Mares”,Veterinary Microbiology, 9, 1984, (pp. 533-542).
Colle et al., “Transcriptional Analyses of the Unique Short Segment of EHV-1 Strain Kentucky A”,Virus Genes, 9, 1995 (pp. 257-268).
Colle et al., “Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces vital titers in mice challenged with a pathogenic strain, RacL”,Virus Research, 43, Jan. 1996 (pp. 112-124).
Crandell, et al., “Vaccination of Pregnant Ponies Against Equine Rhinopneumonitis”,Am. J. Vet. Res., 41, Jul. 1980 ) (pp. 994-996).
Dutta et al., “Immunity and the Level of Neutralization Antibodies in Foals and Mares Vaccinated with a Modified Live-Virus Rhinopneumonitis Vaccine”,Am. J. Vet. Res., 36, Apr. 1975 (pp. 445-448).
Dutta et al., “Cell Mediated Immunity in Equine Herpesvirus Type I Infection 1. In vitro Lymphocyte Blastogenesis and Serum Neutralization Antibody in Normal Parturient and Aborting Mares”,Can. J. comp. Med., 41, Oct. 1977 (p. 404-408).
Dutta et al., “Efficacy of Modified Live-Virus, Equine Rhinopneumonitis Vaccine”,Am. J. Vet. Res., 37, Mar. 1976 (pp. 350-351).
Eaglesome et al., “Equine Herpesvirus 1 Infection in Mares Vaccinated with a Live-virus Rhinopneumonitis Vaccine Attenuated in Cell Culture”,Can. vet. J., 20, May 1979 (pp. 145-147).
Ellis, John A., DVM, Ph.D.; Bogdan; Jaret R.; Kanara, Edward W., DVM; Morely, Paul S., DVM; Haines, Deborah M., DVM, Ph.D., “Cellular and Antigody Reponses to Equine Herpesviruses 1 and 4 Following Vaccination of Horses With Modified-Live and Inactivated Viruses”;JAVMA; Mar. 15, 1995; pp. 823-832; vol. 206, No. 6; American Veterinary Medical Association.
Fitzpatrick et al., “Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus)”,Australian Veterinary Journal, Oct. 1984 (pp. 1947-1952).
Gerber et al., “Effect of Age and Pregnancy on the Antibody and Cell-mediated Immune Responses of Horses to Equine Herpesvirus 1”,Can. J. comp. Med., 41, Oct. 1977 (pp. 471-478).
Gleeson et al., “Responses of Pregnant Mares to Equine Herpesvirus 1 (EHV1)”,Cornell Vet., 70, 1980 (pp. 391-400).
Horner et al., “Isolation of Equine Herpesviruses from Horses with Respiratory Disease”,New Zealand Veterinary Journal, 24, 1976 (pp. 171-176).
Jackson et al., “equine Herpesvirus 1 infection of Horses: Studies on the Experimentally Induced Neurologic Disease”,American Journal of Veterinary Research, 38, Jun. 1977 (pp. 709-719).
Kawakami et al., “Combined Immunizing Effects of Live and Inactivated Equine Herpesvirus 1 in Horses”,Proc. 4thInt. Conf. Equine Infect. Des. Lyn, 1976 (pp. 75-82).
Kemeny, “Antigenic Relationships of Equine Herpesvirus Strains Demonstrated by the Plaque Reduction and Neutralization Kinetics Tests”,Can. J. comp. Med., 35, Oct. 1971 (pp. 279-284).
Kemeny et al., “Isolation of Herpesvirus from Equine Leukocytes: Comparison with Equine Rhinopneumonitis Virus”,Can. J. comp. Med., 34, Jan. 1970 (pp. 59-65).
Kendrick et al., “Immunity to Equine Herpesvirus 1 Infection in Foals During the First Year of Life”,Journals of Reproduction&Fertility Ltd., 27, 1979 (pp. 615-618).
Matsumura et al., “Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses”,Veterinary Microbiology, 48, 1996, (pp. 353-365).
Matumoto et al, “Serologic Survey of Equine Rhinopneumonitis Virus Infection among Horses in Various Countries”,Arch. Ges. Virusforsch., 15, 1965 (pp. 609-624).
Mayr et al., “Charakterisierung enies Stutenabortvirus aus Polen and Vergleich mit bekannten Rhinopneumonitisvirus-Stammen des Pferdes”, Mar. 1965 (pp. 217-230).
Mayr et al., “Zur Differenzierung, Diagnose und Bekämpfung virusbedingter Erkankungen des Pferdes unter besonderer Berücksichtigung der heimischen Kraukheiten”,Berliner und Munchener Tierarztliche Wochenschrift, 1968 (pp. 372-378).
Mitchell, “Vaccines for EHV1 abortion”,The Veterinary Record, Mar. 1983 (p. 285).
O'Callaghan et al., “Equine Herpesv

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Equine herpesvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Equine herpesvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Equine herpesvirus vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3822556

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.